SUPPORTING BIOTECH COMPANIES
in advancing clinical development of large molecule personalized medicine.
Increasing clinical development success
Dr. Anke Domdey
Who We Are
Consultancy company supporting Biotech companies in advancing clinical development of large molecule personalized medicine
Ando focus is on bioanalytical outsourcing and advice on clinical study plans as well as regulatory submissions/ queries in relation to bioanalytical outcome measures relevant for the development of large molecule personalized medicine.
Ando spoke about the Importance of Immunogenicity Investigations in Clinical Development of Therapeutic Proteins at a workshop organized by Xendo GmbH, a ProPharma Group company, in collaboration...
Ando particpates in advancing the clinical development of new treatments of pediatric neuroblastoma by Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets based on a range of technologies licensed...